Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Lucira Health stock
Learn how to easily invest in Lucira Health stock.
Lucira Health, an Emeryville, California-based company that develops infectious disease test kits, completed an upsized IPO for $153 million, selling 9 million shares at $17 each.
Shares of LHDX opened at $22.10 and climbed more than 31% in early trading.
How to buy shares in Lucira Health
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LHDX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Lucira Health stock price (NASDAQ: LHDX)Use our graph to track the performance of LHDX stocks over time.
Lucira Health shares at a glance
|Latest market close||$6.43|
|52-week range||$4.23 - $37.99|
|50-day moving average||$6.64|
|200-day moving average||$7.15|
|Wall St. target price||$8.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.89|
Buy Lucira Health shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Lucira Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lucira Health price performance over time
|1 week (2022-01-11)||-20.12%|
|1 month (2021-12-17)||17.98%|
|3 months (2021-10-18)||11.25%|
|6 months (2021-07-16)||-3.89%|
|1 year (2021-01-14)||N/A|
|2 years (2020-01-14)||N/A|
|3 years (2019-01-14)||N/A|
|5 years (2017-01-14)||N/A|
Lucira Health financials
|Revenue TTM||$32.2 million|
|Gross profit TTM||$-1,672,000|
|Return on assets TTM||-27.89%|
|Return on equity TTM||-55.03%|
|Market capitalisation||$325.2 million|
TTM: trailing 12 months
Lucira Health share dividends
We're not expecting Lucira Health to pay a dividend over the next 12 months.
You may also wish to consider:
- Agilent Technologies (A.US) (0.58% forward annual dividend yield)
Lucira Health overview
Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co. , Ltd. ; technical services agreement with Jabil, Inc.
Lucira Health in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
50 Biggest Movers From Yesterday
28 Stocks Moving In Wednesday's Mid-Day Session
Frequently asked questionsWhat percentage of Lucira Health is owned by insiders or institutions?
Currently 10.88% of Lucira Health shares are held by insiders and 61.095% by institutions. How many people work for Lucira Health?
Latest data suggests 102 work at Lucira Health. When does the fiscal year end for Lucira Health?
Lucira Health's fiscal year ends in December. Where is Lucira Health based?
Lucira Health's address is: 1412 62nd Street, EmeryVille, CA, United States, 94608 What is Lucira Health's ISIN number?
Lucira Health's international securities identification number is: US54948U1051
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
How to buy HeartCore Enterprises (HTCR) stock when it goes public
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.
Ask an Expert